Compare TFPM & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFPM | STVN |
|---|---|---|
| Founded | 2016 | 1949 |
| Country | Canada | Italy |
| Employees | N/A | N/A |
| Industry | Precious Metals | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | TFPM | STVN |
|---|---|---|
| Price | $36.89 | $19.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $32.33 | $23.75 |
| AVG Volume (30 Days) | ★ 605.6K | 294.8K |
| Earning Date | 02-18-2026 | 03-05-2026 |
| Dividend Yield | ★ 0.61% | 0.32% |
| EPS Growth | N/A | ★ 19.61 |
| EPS | ★ 1.01 | 0.60 |
| Revenue | $344,001,000.00 | ★ $1,373,219,524.00 |
| Revenue This Year | $42.63 | $8.42 |
| Revenue Next Year | $11.85 | $9.61 |
| P/E Ratio | $37.34 | ★ $33.04 |
| Revenue Growth | ★ 39.55 | 6.97 |
| 52 Week Low | $15.45 | $17.81 |
| 52 Week High | $37.60 | $28.00 |
| Indicator | TFPM | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.85 | 38.77 |
| Support Level | $35.83 | $20.19 |
| Resistance Level | $37.60 | $21.23 |
| Average True Range (ATR) | 1.21 | 0.76 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 87.12 | 0.00 |
Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.